Skip to main content
. 2022 Oct 17;114(12):1636–1645. doi: 10.1093/jnci/djac165

Table 3.

Association of hair product use frequency, color of dyes, and duration of use with uterine cancer in the Sister Study

Hair product usea Person-years Full cohort Case Age-adjusted HR (95% CI)c Fully adjusted HR (95% CI)c,d
No. (%)b No. (%)b
Permanent dyes
 Frequency in the past 12 months prior to baseline
  Never 162 425 14 795 (44.4) 184 (49.9) Referent Referent
  ≤4 times 83 284 7740 (23.2) 64 (17.3) 0.80 (0.60 to 1.06) 0.79 (0.59 to 1.05)
  >4 times 117 166 10 791 (32.4) 121 (32.8) 0.92 (0.73 to 1.16) 0.98 (0.78 to 1.24)
   Ptrende .44 .77
 Color used in the past 12 months prior to baseline
  Never 162 425 14 795 (44.4) 184 (49.9) Referent Referent
  Light colorf 107 507 9895 (29.6) 98 (26.5) 0.87 (0.69 to 1.10) 0.93 (0.73 to 1.18)
  Dark colorf 111 846 10 401 (31.2) 101 (27.4) 0.92 (0.72 to 1.16) 0.91 (0.72 to 1.16)
 Duration of use, lifetime
  Never 128 528 11 660 (35.4) 151 (41.8) Referent Referent
  <5 years 61 572 5688 (17.3) 48 (13.3) 0.76 (0.55 to 1.06) 0.75 (0.54 to 1.04)
  5 to <10 years 55 141 5064 (15.4) 50 (13.9) 0.83 (0.60 to 1.14) 0.84 (0.61 to 1.15)
  ≥10 years 113 108 10 494 (31.9) 112 (31.0) 0.80 (0.63 to 1.03) 0.82 (0.64 to 1.05)
   Ptrende .10 .14
Semipermanent dyes
 Frequency in the past 12 months prior to baseline
  Never 293 148 26 829 (80.5) 307 (82.7) Referent Referent
  ≤4 times 41 738 3903 (11.7) 35 (9.4) 0.92 (0.65 to 1.31) 0.91 (0.63 to 1.29)
  >4 times 27 852 2581 (7.7) 29 (7.8) 0.96 (0.65 to 1.40) 0.98 (0.67 to 1.44)
   Ptrende .69 .77
 Color used in the past 12 months prior to baseline
  Never 293 148 26 829 (80.5) 307 (82.7) Referent Referent
  Light colorf 25 324 2339 (7.0) 19 (5.1) 0.72 (0.45 to 1.14) 0.73 (0.46 to 1.17)
  Dark colorf 46 522 4364 (13.1) 44 (11.9) 1.02 (0.74 to 1.40) 1.03 (0.74 to 1.42)
 Duration of use, lifetime
  Never 249 458 22 877 (70.1) 254 (71.1) Referent Referent
  <5 years 54 979 5014 (15.4) 49 (13.7) 0.94 (0.69 to 1.27) 0.93 (0.69 to 1.27)
  5 to <10 years 25 424 2326 (7.1) 28 (7.8) 1.08 (0.73 to 1.60) 1.15 (0.78 to 1.70)
  ≥10 years 25 570 2414 (7.4) 26 (7.3) 0.91 (0.61 to 1.36) 0.90 (0.60 to 1.35)
   Ptrende .78 .85
Straighteners, relaxers, or pressing products
 Frequency in the past 12 months prior to baseline
  Never 333 535 30 329 (90.9) 332 (89.7) Referent Referent
  ≤4 times 14 268 1464 (4.4) 12 (3.2) 1.06 (0.59 to 1.88) 1.20 (0.63 to 2.29)
  >4 times 15 464 1572 (4.7) 26 (7.0) 2.19 (1.47 to 3.26) 2.55 (1.46 to 4.45)
    Ptrende <.001 .002
Hair permanents or body waves
 Frequency in the past 12 months prior to baseline
  Never 323 483 29 689 (89.0) 316 (85.6) Referent Referent
  ≤2 times 21 293 1951 (5.8) 23 (6.2) 0.99 (0.65 to 1.52) 0.92 (0.60 to 1.41)
  >2 times 18 486 1730 (5.2) 30 (8.1) 1.28 (0.87 to 1.89) 1.11 (0.75 to 1.63)
   Ptrende .24 .71
a

Missing: permanent dyes (2 cases, 137 overall); color of permanent dyes (4 cases, 168 overall); duration of permanent dye uses (10 cases, 557 overall); semipermanent dyes (150 overall); color of semipermanent dyes (2 cases, 172 overall); duration of semipermanent dyes use (14 cases, 832 overall); straighteners, relaxers, or pressing products (1 case, 98 overall); hair permanents or body waves (2 cases, 93 overall). CI = confidence interval; HR =  hazard ratio.

b

Participants with complete confounder information.

c

Accounted for age by using age as the timescale, where the participants were followed from age at baseline until age at end of follow-up.

d

Adjusted for race and ethnicity (African American/Black, Hispanic/Latina non-Black, non-Hispanic White, other), education (high school or less, some college, college and above), body mass index (restricted cubic spline, continuous, kg/m2), physical activity (metabolic equivalent [MET] hours per week, continuous), menopausal status at enrollment (premenopausal, postmenopausal), parity (0, 1, 2, ≥3), smoking (never, past, or current), alcohol (never or past, current <1 drink, current ≥1 drinks), oral contraceptive use duration (none, <2 years, 2 to <10 years, ≥10 years), hormone replacement therapy (none, estrogen alone, estrogen plus progestin but never estrogen alone), age at menarche (<13 years, ≥13 years old).

e

Assessed using Wald tests for continuous variables of hair product use frequency and duration.

f

Hair color is nonexclusive: participants could be both light and dark users. Both colors were included in the models simultaneously.